Cargando…

Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer

BACKGROUND: Urothelial carcinoma is the most common type of bladder cancer (BC). It makes up more than 90% of all bladder cancers. Uroplakins are tissue-specific, glycoproteins, playing a role in the construction and function of urothelium. The emergence of uroplakins in the urine and/or plasma may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matuszewski, M., Szymańska, B., Długosz, A., Małkiewicz, B., Dembowski, J., Piwowar, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304619/ https://www.ncbi.nlm.nih.gov/pubmed/30627578 http://dx.doi.org/10.1155/2018/8693297

Ejemplares similares

Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis
por: Szymańska, B., et al.
Publicado: (2018)

Initial Evaluation of Uroplakins UPIIIa and UPII in Selected Benign Urological Diseases
por: Szymańska, Beata, et al.
Publicado: (2021)

Uroplakins and their potential applications in urology
por: Matuszewski, Michal Andrzej, et al.
Publicado: (2016)

Low molecular weight proteins and enzymes in the urine of patients with bladder cancer – a pilot study
por: Marchewka, Zofia, et al.
Publicado: (2018)

The Dependence between Urinary Levels of Angiogenesis Factors, 8-Iso-prostaglandin F2α, ɣ-Synuclein, and Interleukin-13 in Patients with Bladder Cancer: A Pilot Study
por: Szymańska, Beata, et al.
Publicado: (2020)

Glycosylation of uroplakins. Implications for bladder physiopathology
por: Kątnik-Prastowska, Iwona, et al.
Publicado: (2014)

Bacteria-Induced Uroplakin Signaling Mediates Bladder Response to Infection
por: Thumbikat, Praveen, et al.
Publicado: (2009)

Expressions of Uroplakins in the Mouse Urinary Bladder with Cyclophosphamide-Induced Cystitis
por: Choi, Seong Hoo, et al.
Publicado: (2009)

Generation of divergent uroplakin tetraspanins and their partners during vertebrate evolution: identification of novel uroplakins
por: DeSalle, Rob, et al.
Publicado: (2014)

Uroplakins in the Lower Urinary Tract
por: Lee, Gilho
Publicado: (2011)

High Expression of Human Uroplakin Ia in Urinary Bladder Transitional Cell Carcinoma
por: Kageyama, Susumu, et al.
Publicado: (2002)

Expression of Uroplakin Ib and Uroplakin III Genes in Tissues and Peripheral Blood of Patients with Transitional Cell Carcinoma
por: Yuasa, Takeshi, et al.
Publicado: (1998)

Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly
por: Deng, Fang-Ming, et al.
Publicado: (2002)

Uroplakin Peptide-Specific Autoimmunity Initiates Interstitial Cystitis/Painful Bladder Syndrome in Mice
por: Izgi, Kenan, et al.
Publicado: (2013)

Changes in uroplakin expression in the urothelium of patients with ulcerative interstitial cystitis/bladder pain syndrome
por: Cho, Kang Jun, et al.
Publicado: (2020)

The role of TSG-6 and uroplakin III in bladder pain syndrome/ interstitial cystitis in rats and humans
por: Lv, Yi-Song, et al.
Publicado: (2017)

The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens
por: Szymańska, Beata, et al.
Publicado: (2017)

Comparison of Antibodies to Detect Uroplakin in Urothelial Carcinomas
por: Kristoffersen, Heidi L., et al.
Publicado: (2022)

Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer
por: Sawicka, Ewa, et al.
Publicado: (2019)

Attachment of Cancer Urothelial Cells to the Bladder Epithelium Occurs on Uroplakin-Negative Cells and Is Mediated by Desmosomal and Not by Classical Cadherins
por: Jerman, Urška Dragin, et al.
Publicado: (2021)

Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins
por: Saban, Marcia R, et al.
Publicado: (2007)

Uroplakins Do Not Restrict CO(2) Transport through Urothelium
por: Zocher, Florian, et al.
Publicado: (2012)

Membrane microdomain-associated uroplakin IIIa contributes to Src-dependent mechanisms of anti-apoptotic proliferation in human bladder carcinoma cells
por: Kihira, Shigeru, et al.
Publicado: (2012)

Long Noncoding RNA Expression Profiling Reveals Upregulation of Uroplakin 1A and Uroplakin 1A Antisense RNA 1 under Hypoxic Conditions in Lung Cancer Cells
por: Byun, Yuree, et al.
Publicado: (2020)

Patient comfort during flexible and rigid cystourethroscopy
por: Krajewski, Wojciech, et al.
Publicado: (2016)

Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases
por: Kong, Xiang-Tian, et al.
Publicado: (2004)

Heterogeneity of uroplakin localization in human normal urothelium, papilloma and papillary carcinoma
por: Zupancic, Dasa, et al.
Publicado: (2013)

Pro-Inflammatory Cytokine Gene Expression in Penile Cancer: Preliminary Studies
por: Czajkowski, Mateusz, et al.
Publicado: (2023)

Evaluation of non-invasive tests as diagnostic tools in assessment of bladder outlet obstruction severity in men with anterior urethral stricture
por: Krukowski, Jakub, et al.
Publicado: (2021)

Urological complications after renal transplantation – a single centre experience
por: Krajewski, Wojciech, et al.
Publicado: (2016)

Ablation of Uroplakin III Gene Results in Small Urothelial Plaques, Urothelial Leakage, and Vesicoureteral Reflux
por: Hu, Ping, et al.
Publicado: (2000)

Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins
Publicado: (1994)

MAL facilitates the incorporation of exocytic uroplakin-delivering vesicles into the apical membrane of urothelial umbrella cells
por: Zhou, Ge, et al.
Publicado: (2012)

Reduced Expression of Uroplakin 1A Is Associated with the Poor Prognosis of Gastric Adenocarcinoma Patients
por: Zheng, Yan, et al.
Publicado: (2014)

Salvage local therapy for radiation-recurrent prostate cancer – where are we?
por: Zdrojowy, Romuald, et al.
Publicado: (2016)

Treatment with low-energy shock wave alleviates pain in an animal model of uroplakin 3A-induced autoimmune interstitial cystitis/painful bladder syndrome
por: Li, Huixi, et al.
Publicado: (2019)

Review of current optical diagnostic techniques for non-muscle-invasive bladder cancer
por: Kołodziej, Anna, et al.
Publicado: (2016)

Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat
por: Akaihata, Hidenori, et al.
Publicado: (2023)

Potential of the cell-free blood-based biomarker uroplakin 2 RNA to detect recurrence after surgical resection of lung adenocarcinoma
por: Zhu, Ji, et al.
Publicado: (2021)

Uroplakins play conserved roles in egg fertilization and acquired additional urothelial functions during mammalian divergence
por: Liao, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4ib3mp0npbg2hd3ovsjvqa5f5l